Frontlight ResearchEarly access
Trial site
Stony Brook University Cancer Center
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Melanoma4 trials
- Childhood cancers2 trials
- Head and neck cancer2 trials
- Lung cancer2 trials
- Prostate cancer2 trials
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Metastatic breast cancer1 trial
- Thyroid cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 23 trials
- Phase 11 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Pfizer2 trials
- Criterium, Inc.1 trial
- ECOG-ACRIN Cancer Research Group1 trial
- Personalis Inc.1 trial
- Replimune, Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Thyroid cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Completed
Terminated
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Completed
Completed
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Site data: ClinicalTrials.govUpdated 12 Nov 2026